{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-008343","form_type":"8-K","ticker":"ENSC","cik":"0001716947","company_name":"Ensysce Biosciences, Inc.","filed_at":"2026-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.988088+00:00","generated_at":"2026-05-15T23:06:56.646464+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"confidence":"high","headline":"Ensysce Biosciences receives Nasdaq deficiency notice for bid price below $1","bullets":["Received Nasdaq deficiency letter on Feb 25, 2026; bid price closed below $1 for 30 consecutive business days.","Company has 180 days, until August 24, 2026, to regain compliance by closing at $1 for 10 consecutive days.","If not compliant by Aug 24, Nasdaq may grant a second 180-day period if other listing standards met.","Company intends to monitor bid price and evaluate options; trading on Nasdaq continues under ENSC.","Failure to regain compliance could lead to delisting, impairing capital raising and market liquidity."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-008343","json":"https://secwatch.observer/filing/0001493152-26-008343.json","markdown":"https://secwatch.observer/filing/0001493152-26-008343.md","text":"https://secwatch.observer/filing/0001493152-26-008343.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716947/000149315226008343/0001493152-26-008343-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716947/000149315226008343/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:06:56.646464+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}